Viewing Study NCT00005959


Ignite Creation Date: 2025-12-24 @ 3:05 PM
Ignite Modification Date: 2026-01-01 @ 3:29 PM
Study NCT ID: NCT00005959
Status: UNKNOWN
Last Update Posted: 2013-12-04
First Post: 2000-07-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module